Precede Biosciences competitors & alternatives

Predicine Holdings LtdBiotechnology

78% matchPrivate

Biotechnology

Predicine Holdings Ltd provides next-generation liquid biopsy platforms and molecular profiling services for cancer research and precision medicine. The company utilizes proprietary blood- and urine-based assays to analyze circulating tumor DNA and RNA, serving biopharmaceutical partners and clinical researchers in oncology drug development and clinical trials.

Predicta, Inc.BiotechnologyUnited States

74% matchPrivate

Biotechnology

Predicta Biosciences is a precision oncology company that builds a molecular insights platform for blood cancer care. By utilizing a single blood sample, the company integrates multiomics and liquid biopsies to generate longitudinal genomic and immune insights for diagnostics.

Biotechnology

Resolution Bioscience is a precision medicine company specializing in cancer diagnostics, DNA sequencing, and liquid biopsy, located in Bellevue, Washington.

LucenceBiotechnologySingapore

72% match

Biotechnology

Lucence is a precision oncology and health diagnostics company that provides ultrasensitive liquid biopsy tests, including cancer screening, treatment selection, and health risk assessment solutions. Using proprietary technologies like AmpliMARK, the company analyzes blood-based genetic material to detect cancer mutations, early-stage malignancies, and cardiovascular risks for patients and healthcare providers.

Similar biotech company

Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).

Capio Biosciences, Inc.BiotechnologyUnited States

70% matchPrivate

Biotechnology

Capio Biosciences is an oncology diagnostics company that develops advanced technologies for capturing and analyzing circulating tumor cells (CTCs) from whole blood. Its proprietary CapioCyte platform offers enhanced sensitivity compared to traditional methods, serving as a research tool designed to help oncologists make informed cancer treatment decisions.

Saga Bio, Inc.BiotechnologyUnited States

70% matchPrivate

Biotechnology

SAGA Diagnostics provides ultra-sensitive, blood-based molecular residual disease (MRD) detection and monitoring tests for cancer patients. The company's flagship platform, Pathlight, uses tumor whole-genome sequencing and personalized digital PCR assays to detect circulating tumor DNA, primarily serving clinicians and biopharmaceutical partners for early cancer detection and treatment tracking.

BillionToOneBLLN · BiotechMenlo Park, United States

70% matchPublic

Similar biotech company

BillionToOne is a molecular diagnostics company that develops single-molecule counting technology for prenatal screening and oncology. The company provides non-invasive prenatal tests (NIPT) to assess fetal risk from maternal blood samples, alongside pan-cancer liquid biopsy tests for therapy selection and treatment monitoring.

NovigenixBiotech, DiagnosticsSwitzerland

68% match

Biotech, Diagnostics

Novigenix is an immuno-transcriptomics and TechBio company that provides precision oncology solutions for biopharmaceutical companies and researchers. It offers LITOseek, an AI-powered liquid biopsy platform that analyzes gene activity in immune cells to support biomarker discovery, therapy development, and patient response monitoring.

Signatur BiosciencesBiotechnology

68% match

Biotechnology

Signatur Biosciences develops a molecular diagnostic platform that utilizes standard qPCR equipment to analyze complex RNA signatures and perform precision testing for diseases such as breast cancer. The company's kits are designed to decentralize diagnostics by replacing complex, expensive laboratory workflows with simplified assays compatible with existing hospital infrastructure.

Adela, Inc.Diagnostics/ToolsUnited States

68% match

Diagnostics/Tools

Adela, Inc. is an epigenomics-focused biotechnology company headquartered in Foster City, California. The company is advancing breakthrough approaches for the early detection of multiple types of cancer through blood tests.

Biotechnology

ExosomeDx (Exosome Diagnostics) develops noninvasive liquid-biopsy diagnostics based on RNA carried in exosomes, including the ExoDx Prostate test for assessing prostate-cancer risk. Its products serve urologists, oncologists, laboratories, and patients by supporting clinical decision-making without relying solely on invasive biopsy.